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Although protein–protein interactions (PPIs) have emerged as the basis of potential new therapeutic 
approaches, targeting intracellular PPIs with small molecule inhibitors is conventionally considered 
highly challenging. Driven by increasing research efforts, success rates have increased significantly 
in recent years. In this study, we analyze the physicochemical properties of 9351 non-redundant 
inhibitors present in the iPPI-DB and TIMBAL databases to define a computational model for active 
compounds acting against PPI targets. Principle component analysis (PCA) and k-means clustering 
were used to identify plausible PPI targets in regions of interest in the active group in the chemical 
space between active and inactive iPPI compounds. Notably, the uniquely defined active group 
exhibited distinct differences in activity compared with other active compounds. These results 
demonstrate that active compounds with regions of interest in the chemical space may be expected to 
provide insights into potential PPI inhibitors for particular protein targets.
Protein–protein interactions (PPIs) play central roles in almost all intracellular and extracellular biological 
processes and are essential to the mechanisms of various diseases and pathological conditions such as neuro-
degeneration, cardiovascular diseases, and  cancer1–4. Approximately 650,000 PPIs are known to be present in 
each human cell, suggesting that 650,000 potential targets may exist for modifying cellular biological functions 
using  drugs5–8. Although PPI-related crucial functions have been demonstrated in numerous disease states and 
have attracted increasing research attention as an emerging class of molecular targets, they have been conven-
tionally considered intractable for small-molecule modulators owing to druggability issues and their large and 
flat  interfaces9–11. However, small-molecule PPI inhibitors and PPI-focused chemical libraries have recently 
been improved as a result of the development of high-throughput experiments and in silico technologies such 
as cheminformatics and machine learning  tools12–19. Historically, the molecular topography of most known PPI 
inhibitors has been shown to share common surface features such as being more shallow, large, and hydrophobic 
than typical orally available drugs. Thus, PPI inhibitors are larger, more hydrophobic, more rigid, and contain 
multiple aromatic  rings5,8. Over recent decades, many PPI inhibitors have been screened for their action against 
PPI-related targets and have achieved considerable clinical success in the treatment of autoimmune diseases 
and  cancer20,21. Moreover, the physicochemical and pocket properties of PPI inhibitors have been identified 
through PPI-specific database analysis; studies have suggested that PPI target classes with matching regions in 
both chemical and target spaces could facilitate the development of iPPIs to the stage of drug  candidates1,22,23.
However, individual PPI target analyses based on PPI-specific databases incorporating the chemical and 
physical characteristics of these compounds have thus far remained insufficient. Moreover, no study has focused 
on the methods by which knowledge of an “active” or “inactive” result from a bioassay could be used to design 
PPI inhibitors; successful examples have also not been reported in the relevant literature. Compared with most 
non-PPI inhibitors, the average molecular weight of PPI inhibitors is significantly greater than 500 Da; however, 
this trend has been driven, in large part, by the contribution of peptide-based  compounds2,24. Therefore, further 
analysis must be conducted based on a limited region of small molecules in the PPI database, referred to as the 
biologically relevant chemical space for each PPI target.
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In this study, we compared active and inactive datasets to identify promising active compounds for each PPI 
target. To characterize chemicals and predict their experimental activities, cheminformatics techniques with 
very high reliability are required to enable the evaluation of experimental values such as pKi or IC50. Thus, we 
developed predictive computational models to identify and prioritize the most promising chemicals. In addition 
to investigating the physicochemical property distributions of these compounds using molecular descriptors, 
we also visualized them in structural chemistry space using principal component analysis (PCA) and a k-means 
clustering algorithm. Then, we determined PPI-specific targets with regions of interest of the active group in the 
chemical space and observed that active compounds in such regions of interest exhibited potent profiles com-
pared to weakly active and inactive compounds. We also show that the seven molecular descriptors used as the 
basis of the computational model can provide useful information regarding the unique chemical characteristics 
of Bcl-2 active compounds and assist in differentiating most active Bcl-2  inhibitors25–28.
Materials and methods
Dataset preparation. The iPPIs dataset was generated from iPPI-DB (https:// ippidb. paste ur. fr/) and TIM-
BAL (http:// mordr ed. bioc. cam. ac. uk/ timbal/)  databases15,16,19. After removing redundant compounds, non-
redundant datasets comprising 1756 and 7610 compounds were obtained for the iPPI-DB and TIMBAL data-
bases, respectively. The activity values  (Kd, Ki,  IC50, and  EC50) of the various compounds were used to classify 
them as active or inactive. Compounds with activity values of less than 30 μΜ were categorized as “active” com-
pounds. The dataset used for PCA and clustering was constructed using 9351 iPPI compounds. The two datasets 
(iPPI-DB dataset and active portion of TIMBAL dataset) were merged, 15 duplicated compounds were removed. 
Subsequently, we constructed datasets for each PPI target, and sets of Bcl-2 and MDM2 protein compounds were 
obtained with 992 and 932 members, respectively, and subjected to further analysis.
Principal component analysis (PCA) and cluster analysis. A molecular descriptor is defined as a 
numerical description computationally representing physical and chemical information of compounds. Such 
descriptor parameters were generated for the two datasets using the molecular descriptor calculator included 
in the QikProp module of the Schrödinger platform (Maestro, Schrödinger, LLC, New York, NY, 2020). The 
calculated descriptors included molecular weight, number of hydrogen bond acceptors, number of hydrogen 
bond donors, ALogP, number of rotatable bonds, number of aromatic rings, and polar surface area. PCA is a 
multivariate statistical method used in exploratory data analysis. It allows the representation of the property 
space by perspective projection into a principal component plane (PC1, PC2), encoding the data from a given 
mathematical  viewpoint29–35. To extract the most important information from the dataset, PCA was employed 
to explore the chemical space of iPPI inhibitors as a function of these seven molecular descriptors using the Fac-
toMineR R  package36,37. PCA-clustering values were calculated on the iPPI dataset using the k-means clustering 
method within the Factoextra R packages. All histograms and scatter plots were generated using the R software.
Docking simulation. To understand the affinity of protein–ligand binding, a molecular docking approach 
was employed. Sets of 992 active Bcl-2 inhibitors were simulated by a docking program. To evaluate the bind-
ing mode and affinity of the dataset to the Bcl-2 target proteins, the crystal structures were retrieved from the 
RCSB Protein Data Bank (PDB ID:2YXJ). Molecular docking studies were performed using Glide (Schrödinger, 
LLC, New York, NY, 2020), which uses the OPLS-2005 force field, and refinement was performed according to 
the recommendations of the Protein Preparation  Wizard38,39. LigPrep (Schrödinger, LLC, New York, NY, 2020) 
was used to generate the 3D structures of the ligands. The active grid was generated using the Receptor grid 
application in the Glide module. On a defined receptor grid, flexible docking was performed using the standard 
docking precision (SP) mode of Glide. The best docking pose for a given compound was selected based on the 
best scoring conformations from the Glide score.
Results and discussion
Development of iPPI datasets. To analyze the unique chemical properties of PPI inhibitors, we gener-
ated datasets of PPI inhibitors from the iPPI-DB and TIMBAL databases including small molecules inhibiting 
 PPIs15,16,19. The datasets were checked for redundancy. The datasets contained 9351 non-redundant inhibitors. 
The iPPI-DB database contained 1756 inhibitors for 18 targets, while TIMBAL database contained 7610 inhibi-
tors for 34 targets (Supplementary Fig. S1). We then classified the PPI inhibitor compounds present in the iPPI-
DB and TIMBAL databases into active and inactive categories; the compounds with dose response values equal 
to or lower than 30 μM were retained as the active group, and others were classified as the inactive group.
Thus, the datasets containing the 9351 chemicals were designated as active iPPI datasets and inactive iPPI 
datasets; 8066 compounds were active (PPI inhibitors) and 1285 were inactive (non-PPI inhibitors). The active 
and inactive datasets were designed to compare the physicochemical properties of active and inactive compounds 
on PPI targets. As shown in Fig. 1, we observed that the frequency distribution of PPI inhibitors in the iPPI-DB 
and TIMBAL databases was biased to only a small number of targets. These results indicated that random sam-
pling over entire PPI targets might cover only a limited number of compounds and targets. Analyzing each PPI 
target was expected to provide a more accurate result for the active dataset, which is conventionally performed 
for broad datasets of PPI inhibitors. Therefore, the selected iPPI datasets based on partially limited targets can 
be expected to provide some clues to establish key points regarding the differences between active and inactive 
compounds on each PPI target.
Comparative study on molecular descriptors of iPPI datasets. To investigate the distinct features of 
the active and inactive datasets for iPPI compounds and to compare them, seven molecular descriptors of each 
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molecule (molecular weight, ALogP, number of hydrogen bond acceptors, number of hydrogen bond donors, 
the number of rotatable bonds, number of aromatic rings, and polar surface area) were calculated and applied 
to perform PCA. The frequency distribution of physicochemical properties for the total iPPI datasets along with 
the active/inactive datasets is shown in Fig. 2, and a summary of the mean values of the seven molecular descrip-
tors for dataset of each PPI target is given in Table 1.
The histogram plots of the active/inactive dataset showed that the distributions of the seven molecular 
descriptors broadly overlapped between the two datasets (dark green regions shown in Fig. 2A–G). Comparison 
Figure 1.  Distributions of compounds for target proteins of iPPI datasets. The colored histogram shows the 
frequency distribution against numbers of known compounds for each PPI target. Panels (A) and (B) indicate 
results for the active and inactive groups in the iPPI datasets, respectively.
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was performed using a two-sided Student’s t-test to determine whether the difference in descriptor distributions 
between the two datasets was significant, and the analysis showed that all descriptors were significantly different 
Figure 2.  Physicochemical profile of compounds from iPPI datasets. (A–G) Chemical properties of the 
compounds from the iPPI datasets are compared using the histogram for the seven molecular descriptors. The 
dotted lines represent mean values, and the histogram bars of the active and inactive group are colored red 
and light green, respectively, whereas the dark green bar represents the overlap region. (H) Distribution of the 
chemical space of the compounds in the iPPI datasets according to principal component analysis. All histograms 
and scatter plots were generated using the R software.
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(p < 0.05). The mean values of the seven descriptors of the active dataset were greater than those of the inactive 
dataset (Table 1). By contrast, the mean value of the polar surface area (PSA) of the inactive dataset was signifi-
cantly smaller than that of the active dataset. These results indicate that compounds within the active dataset 
possessed less polar surface area and were more lipophilic than those in the inactive dataset.
We performed PCA to compare the diversity of the two datasets. This projection provides a simplified view 
of the chemical space by reducing the dimensionality of the calculated descriptors according to a linear trans-
formation. The accumulated variance showed that the two principal components, PC1 and PC2, represented 
80.2% of the total variance, contributing 48.7% and 31.5%, respectively. As shown in Fig. 2H, PCA was applied 
to the seven descriptors, and the two datasets shared a common chemical space region. For the inactive dataset, 
the scatter plots of PC1 and PC2 showed that the chemical space was near that of the active dataset and largely 
clustered into a single group. However, we also identified that compounds in the active dataset occupied some 
distinct regions of interest. Therefore, separate datasets were constructed to characterize the distinct features of 
the chemical spaces of the active and inactive datasets.
Diversity analysis for each PPI target dataset. To test whether the overlapping patterns in the chemi-
cal space between the two datasets we identified in Fig. 2H were statistically common key sources across the 43 
PPI targets, we performed PCA on the active and inactive groups for each PPI target class. As shown in Sup-
plementary Table S1, eight target proteins, including Bcl-2, BRD, Cyclophilins, HIF1a, ImmunophilinFKBP1A, 
Integrins, MDM2, and XIAP, were selected as containing more than 100 compounds in the active group and also 
being present in the inactive group.
The PCA scatter plot of the calculated physicochemical properties of each of the eight target proteins visually 
represents the active/inactive datasets, as described by the first two significant principal components (Fig. 3 and 
Supplementary Fig. S2). From the PCA of the eight target proteins, we identified that most of the target proteins 
shared a chemical space between the active and inactive groups.
In only the Bcl-2 and MDM2 datasets, the most prominent pattern observed in the chemical space was 
similar to that of the total PPI datasets, with both vast chemical diversity and regions of interest in the active 
group (Fig. 3A,B). As shown in Figure 3, the large number of data points in the active group for the Bcl-2 target 
protein differing significantly from the observations of the inactive group indicates a wider sampling distribution 
of the chemical space compared with the inactive dataset. The chemical spaces of the integrins and XIAP target 
proteins also showed a similar pattern of regions of interest to that of the total PPI dataset, but did not show a 
large number of data points with non-overlapping regions in the active group compared to the Bcl-2 and MDM2 
datasets and were excluded from further study (Supplementary Fig. S2E,F).
PCA-based clustering of Bcl-2 and MDM2 datasets. By performing PCA on the active/inactive data-
set of Bcl-2 and MDM2, we identified similar patterns in the chemical space when PCA was applied to the com-
plete dataset for all PPI targets. Particularly, the PCA-based visualization of the chemical space for the Bcl-2 and 
MDM2 inhibitors identified that a difference in active and inactive datasets was apparent. The clear difference in 
chemical space between the active and inactive dataset could aid in discriminating the most active compounds 
from moderate active and inactive compounds.
Next, we used k-means clustering to further investigate this idea and clustered the Bcl-2 and MDM2 datasets 
into seven molecular descriptor spaces (Fig. 3C,D). For the Bcl-2 dataset, we found the optimal clustering to 
be two clusters grouped together with active and inactive compounds, and that regions of interest were pre-
dominantly occupied by some active compounds in Cluster 2. In addition, through total iPPI dataset analysis, 
we confirmed that most active compounds present in the regions of interest belonged to the two target proteins 
Bcl-2 and MDM2 (Supplementary Fig. S3A,B). These results indicate that physicochemical descriptor-based 
clustering could accurately classify active and inactive compounds in the Bcl-2 dataset, such that compounds 
with similar activity were clustered together in the chemical space. In contrast, clustering using MDM2 datasets 
did not provide the optimum number of clusters grouped into active and inactive compounds in the chemical 
space. Figure 3D shows that the model did not accurately determine the classes of active and inactive compounds 
in MDM2 using the k-mean based clustering algorithm.
Classification of physicochemical environment for Bcl-2 dataset. PCA and clustering of these 
seven chemical descriptors allowed us to establish a trend in the availability and distribution of the compounds, 
yielding five classes of physicochemical environments: Class 1, indicating total Bcl-2 compounds in Clusters 1 
and 2; Class 2, indicating active compounds in Clusters 1 and 2; Class 3, indicating active compounds in Cluster 
Table 1.  Summary of the chemical properties distributions and comparison of the active/inactive dataset. MW 
mean of molar weight, ALog P mean of logarithm of the calculated octan-1-ol–water partition coefficient, HBA 
mean number of hydrogen bond acceptors, HBD mean number of hydrogen bond donors, NRB mean number 
of rotatable bonds, PSA mean number of polar surface area.
Dataset Size MW (Da) ALogP HBA HBD NRB NAR PSA
Active 8066 533.4 3.51 6.00 2.89 8.78 2.69 0.24
Inactive 1285 438.5 2.53 5.51 2.69 7.37 2.22 0.26
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1; Class 4, containing active compounds in Cluster 2; and Class 5, representing inactive compounds in Cluster 1. 
Classes 1, 2, 3, 4, and 5 contained 1150, 992, 531, 461, and 158 Bcl-2 compounds, respectively (Fig. 4A–E). Inter-
estingly, the PCA plot of active compounds in Cluster 2 (Class 4) showed a clear separation of active compounds 
in Cluster 1 (Class 3) (Fig. 3A). To identify new and unique characteristics of Bcl-2 active compounds present 
in Cluster 2, PCA was performed on the Bcl-2 datasets using the same seven molecular descriptors. As for Class 
4, PC1 afforded the highest variance with a value of 50.5%, and PC2 provided the second-highest variance with 
a value of 23.1%. In particular, the loading plot shows that the positive end of PC1 was dominated by number 
of hydrogen bond acceptors (NHA), number of rotatable bonds (NRB), and number of hydrogen bond donors 
(NHD), thereby suggesting the importance of these descriptors in accounting for the variance of PC1 and PC2.
In contrast to that of Class 4, the loading plot of all other classes indicated that the positive end of PC1 was 
dominated by molecular weight, NRB, and NHA. Supplementary Figure S4 shows the top variables contributing 
to PC1 in a bar plot. The red dashed line on the graph indicates the expected average contribution. Therefore, 
the NHD descriptor, found only in Class 4, could be considered as an important contributor to the component. 
From these results, we identified a subset of descriptors having a clear difference in the profiles of active and 
inactive compounds among the Bcl-2 inhibitors. Taken together, a subset of descriptors comprising the NHD 
descriptor, appearing only in Class 4, was identified to characterize the main features of highly active compounds 
(Fig. 4D). These results could also be of benefit in comprehensively describing relevant physicochemical features 
required in the design of Bcl-2 inhibitors.
Analysis of highly active group on Bcl-2 dataset. To investigate the profile of active Bcl-2 compounds 
on Cluster 2, experimental active values and docking scores for the Cluster 1 and 2 active datasets were com-
pared. Figure 5A,B show the distribution of the docking scores and the experimental active values for the Clus-
ter 1 and 2 active datasets. The distribution of active values and docking scores for the Cluster 2 active dataset 
was also shifted left relative to that of the Cluster 1 active dataset. For active compounds in the Cluster 1 and 2 
datasets, the mean activity values were 5.27 μM and 3.58 μM, respectively (Fig. 5C). The mean docking scores 
of active compounds in Clusters 1 and 2 were − 6.197 and − 8.524, respectively, indicating that the active com-
pounds of Cluster 2 could be predicted to have higher binding affinity than the active compounds of Cluster 1 
(Fig. 5D). These results indicate that the active compounds in Cluster 2 were more active on average. We showed 
Figure 3.  Visual representation of the chemical space of Bcl-2 and MDM2 dataset. Principal component 
analysis (PCA)-based clustering representing the comparison of the chemical space on active/inactive datasets 
in the Bcl-2 and MDM2 datasets. (A,B) Distribution of the chemical space of the compounds in the Bcl-2 and 
MDM2 dataset according to principal component analysis. The loading plot vectors are represented by arrows 
for each physicochemical property. (C,D) Data points are color-coded by cluster of molecules. The magenta and 
blue dots correspond to active compounds in the clusters 1 and 2, respectively.
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that the seven molecular descriptors used in this study could discriminate highly active Bcl-2 compounds from 
Bcl-2 active compounds and provide valuable guidance for the design and discovery of potent Bcl-2 inhibitors.
Conclusions
PPIs are essential to almost every cellular process from cell proliferation to cell metabolism; therefore, under-
standing PPIs is important in terms of human diseases. Recently, many PPI inhibitors have been widely studied 
as targets for PPI-inhibiting small ligands, and a large amount of data has been rapidly deposited in many public 
PPI databases. Nearly 650,000 PPIs have been identified in humans, and PPI-inhibiting drugs have been identified 
as a highly promising therapeutic approach. Nonetheless, PPIs have historically been considered difficult targets 
to modulate by small molecules because of the 3D structural and biophysical complexity of their interfacial fea-
tures. Therefore, there is a need to identify chemical properties of PPI inhibitors based on curated high-quality 
PPI data. Exploration of the chemical space available in many public PPI databases provides an opportunity to 
analyze the molecular factors relevant to the bioactivity of PPIs.
The iPPI-DB and TIMBAL databases specialize in drug target PPIs and primarily focus on the chemical prop-
erties and information on the biological function of PPI-inhibiting ligands. Analysis of the properties of the two 
databases can provide a synergistic capability to identify novel chemicals inhibiting target PPIs. We hypothesized 
that chemical descriptors could be utilized to better characterize PPI inhibitors and thus construct target-specific 
Figure 4.  PCA plot of BCL-2 dataset. The visual representation was generated with principal component 
analysis of seven drug-like physicochemical properties. The loading plot vectors are represented by arrows for 
each physicochemical property. The blue dots (A), red dots (B), cyan dots (C), magenta dots (D), and green dots 
(E) represent Class 1, 2, 3, 4, and 5, respectively.
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models with enhanced prediction performance. Therefore, we used a k-means clustering algorithm in a PCA-
based chemical space to analyze large datasets of PPI inhibitors to explore the biologically relevant chemical 
space. The PCA results showed that most of the target proteins shared a common chemical space between the 
active and inactive compound groups. However, only datasets of Bcl-2 and MDM2 among the eight target 
proteins showed an overlap pattern in chemical space similar to that of the total PPI datasets and had regions 
of interest in the active group. The selected machine learning techniques used in the present work could be suc-
cessfully applied to confirm highly active compounds by evaluating the chemical properties of each PPI target. 
We compared the coverage of biologically relevant chemical spaces using active compounds of Bcl-2 targets to 
reveal regions populated by highly active compounds, referred to here as regions of interest.
Based on this analysis, we proposed a unique region in the chemical space that could be used to identify highly 
active compounds in the PPI-specific database. In addition, we explored Bcl-2 active compounds to define the 
binding affinity of various compounds against Bcl-2 targets using molecular docking simulation and showed that 
the compounds classified here as highly active compounds had higher binding affinity on average. These tech-
niques could be successfully applied to define a novel Bcl-2 inhibitor profile on the PPI databases. Our analysis 
offers a comprehensive overview of Bcl-2 active compounds and should aid in the design of PPI-target-specific 
chemical libraries and the identification of potential active compounds for drug discovery.
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